Lowell Anthony

Lowell Anthony

University of Kentucky

H-index: 40

North America-United States

About Lowell Anthony

Lowell Anthony, With an exceptional h-index of 40 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Kentucky, specializes in the field of Cancer Biology, neuroendocrine neoplasms, clinical pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

DNA-PK inhibition to enhance radiation sensitivity in metastatic pancreatic neuroendocrine cancer

1198P Phase Ib portion of the ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu somatostatin analogue (SSA …

Abstract CT221: Phase II of frontline maintenance rucaparib in combination with nivolumab in ES SCLC

ACTION-1 phase Ib/3 trial of RYZ101 in somatostatin receptor subtype 2–expressing (SSTR2+) gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu …

Serum Serotonin Compared to Plasma 5-HIAA and Chromogranin A as Biomarkers of Response to Hepatic Artery Bland Embolization

Phase II study of frontline maintenance rucaparib in combination with nivolumab in extensive stage small cell lung cancer

The impact of neighborhood socioeconomic deprivation on clinical trial enrollment at an NCI-designated cancer center.

SSTR-2 expression in solid tumors: An immunohistochemistry analysis

Lowell Anthony Information

University

Position

Professor of Medicine

Citations(all)

7994

Citations(since 2020)

2542

Cited By

6984

hIndex(all)

40

hIndex(since 2020)

24

i10Index(all)

100

i10Index(since 2020)

53

Email

University Profile Page

University of Kentucky

Google Scholar

View Google Scholar Profile

Lowell Anthony Skills & Research Interests

Cancer Biology

neuroendocrine neoplasms

clinical pharmacology

Top articles of Lowell Anthony

Title

Journal

Author(s)

Publication Date

DNA-PK inhibition to enhance radiation sensitivity in metastatic pancreatic neuroendocrine cancer

Cancer Research

Piotr G Rychahou

Aman Chauhan

Zeta Chow

Tadahide Izumi

Quan Chen

...

2024/3/22

1198P Phase Ib portion of the ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu somatostatin analogue (SSA …

Annals of Oncology

J Strosberg

G Ulaner

D Halperin

SH Mehr

D Li

...

2023/10/1

Abstract CT221: Phase II of frontline maintenance rucaparib in combination with nivolumab in ES SCLC

Cancer Research

Aman Chauhan

Jill Kolesar

Donglin Yan

Zhonglin Hao

Ronald McGarry

...

2023/4/14

ACTION-1 phase Ib/3 trial of RYZ101 in somatostatin receptor subtype 2–expressing (SSTR2+) gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu …

Michael Morris

Gary A Ulaner

Daniel M Halperin

Jonathan R Strosberg

Samuel H Mehr

...

2023/6/1

Serum Serotonin Compared to Plasma 5-HIAA and Chromogranin A as Biomarkers of Response to Hepatic Artery Bland Embolization

Endocrine Abstracts

Cole Blanford

Donglin Yan

Ning Li

Alison Woodworth

Gaby Gabriel

...

2023/2/1

Phase II study of frontline maintenance rucaparib in combination with nivolumab in extensive stage small cell lung cancer

Endocrine Abstracts

Aman Chauhan

Jill Kolesar

Donglin Yan

Zhonglin Hao

Ronald McGarry

...

2023/12/15

The impact of neighborhood socioeconomic deprivation on clinical trial enrollment at an NCI-designated cancer center.

Amina Dhahri

Madison Ginn

Benjamin Daniel Powers

Aman Chauhan

John L Villano

...

2023/6/1

SSTR-2 expression in solid tumors: An immunohistochemistry analysis

Endocrine Abstracts

Aman Chauhan

Susanne Arnold

Therese Bocklage

Donglin Yan

Ning Li

...

2023/2/1

ETCTN 10388: A first in human Phase I Trial of Triapine and Lutetium Lu 177 DOTATATE in Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine …

Endocrine Abstracts

Aman Chauhan

Susanne Arnold

Jill Kolesar

William Carson

Heidi Weiss

...

2023/12/15

Pharmacokinetics and RP2D analysis from ETCTN 10388: A phase I trial of triapine and lutetium Lu-177 dotatate in well-differentiated somatostatin receptor–positive …

Aman Chauhan

Susan M Christner

Jan Hendrik Beumer

Charles Kunos

Aman Khurana

...

2023/2/1

Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors

The Oncologist

Yue Cheng

Lowell Anthony

Chris Delcher

Daniela C Moga

Aman Chauhan

...

2023/6/1

Are there any clinical factors associated with PRRT-refractoriness in NET patients?

Endocrine Abstracts

Garima Gupta

Rina Yadav

Donglin Yan

Lowell Anthony

Robert Ramirez

...

2023/12/15

ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Aman Chauhan

Jill Kolesar

Donglin Yan

Daneng Li

Aman Khurana

...

2023/2/1

Abstract CT194: ETCTN 10388: a first in human phase I trial of triapine and lutetium Lu 177 DOTATATE in well-differentiated somatostatin receptor-positive …

Cancer Research

Aman Chauhan

Susanne Arnold

Jill Kolesar

William Carson

Heidi Weiss

...

2023/4/14

68Ga-DOTATATE PET/CT: the optimum standardized uptake value (SUV) internal reference

Academic Radiology

Ahmed Ragab

Jianrong Wu

Xue Ding

Aurela Clark

Blaine Mischen

...

2022/1/1

Inhibition of Ribonucleotide Reductase Subunit 2 (RRM2) Induces Radiosensitization in Gastroenteropancreatic Neuroendocrine Tumors

International Journal of Radiation Oncology, Biology, Physics

Z Chow

J Johnson

A Chauhan

T Izumi

M Cavnar

...

2022/11/1

Long-term treatment with telotristat ethyl in patients with carcinoid syndrome symptoms: Results from the TELEPATH study

Neuroendocrinology

Dieter Hörsch

Lowell Anthony

David J Gross

Juan W Valle

Staffan Welin

...

2022/5/3

Concurrent Everolimus With Hepatic Transarterial Bland Embolotherapy [Evero-Embo] in Patients With Bulky and/or Progressive Metastatic Well-Differentiated Neuroendocrine Tumor

Oncology

Fariha Siddiqui

Aman Chauhan

Gaby E Gabriel

Jianrong Wu

Val R Adams

...

2020/11/1

hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated …

Cancers

Aman Chauhan

Alexandre Prieur

Jill Kolesar

Susanne Arnold

Léa Payen

...

2022/2/9

Randomized, parallel arm, phase II study of telotristat (Xermelo) in combination with lutetium Lu 177 dotatate (Lutathera) in well-differentiated neuroendocrine tumors (NETs).

Aman Chauhan

Charles Kunos

Donglin Yan

Aman Khurana

Riham Khouli

...

2022/1/5

See List of Professors in Lowell Anthony University(University of Kentucky)

Co-Authors

H-index: 104
Wouter de Herder

Wouter de Herder

Erasmus Universiteit Rotterdam

H-index: 99
B. Mark Evers

B. Mark Evers

University of Kentucky

H-index: 94
Vay Liang Go

Vay Liang Go

University of California, Los Angeles

H-index: 91
herbert chen

herbert chen

University of Alabama at Birmingham

H-index: 86
kulke m

kulke m

Harvard University

H-index: 65
Rebecca S. Sippel

Rebecca S. Sippel

University of Wisconsin-Madison

academic-engine